- Home
- UONE vs SGMT Comparison
UONE vs SGMT Comparison
Compare UONE & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONE
- SGMT
- Stock Information
- Founded
- UONE 1980
- SGMT 2006
- Country
- UONE United States
- SGMT United States
- Employees
- UONE N/A
- SGMT N/A
- Industry
- UONE Broadcasting
- SGMT
- Sector
- UONE Consumer Discretionary
- SGMT
- Exchange
- UONE Nasdaq
- SGMT Nasdaq
- Market Cap
- UONE 68.4M
- SGMT 71.2M
- IPO Year
- UONE N/A
- SGMT 2023
- Fundamental
- Price
- UONE $1.64
- SGMT $3.26
- Analyst Decision
- UONE
- SGMT Strong Buy
- Analyst Count
- UONE 0
- SGMT 6
- Target Price
- UONE N/A
- SGMT $25.67
- AVG Volume (30 Days)
- UONE 29.0K
- SGMT 556.2K
- Earning Date
- UONE 05-13-2025
- SGMT 05-08-2025
- Dividend Yield
- UONE N/A
- SGMT N/A
- EPS Growth
- UONE N/A
- SGMT N/A
- EPS
- UONE N/A
- SGMT N/A
- Revenue
- UONE $449,674,000.00
- SGMT N/A
- Revenue This Year
- UONE N/A
- SGMT N/A
- Revenue Next Year
- UONE N/A
- SGMT N/A
- P/E Ratio
- UONE N/A
- SGMT N/A
- Revenue Growth
- UONE N/A
- SGMT N/A
- 52 Week Low
- UONE $1.23
- SGMT $1.73
- 52 Week High
- UONE $3.33
- SGMT $7.38
- Technical
- Relative Strength Index (RSI)
- UONE 65.21
- SGMT 52.50
- Support Level
- UONE $1.38
- SGMT $3.19
- Resistance Level
- UONE $1.70
- SGMT $3.45
- Average True Range (ATR)
- UONE 0.11
- SGMT 0.31
- MACD
- UONE 0.02
- SGMT 0.05
- Stochastic Oscillator
- UONE 84.29
- SGMT 51.27
About UONE Urban One Inc.
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.